Focus on Equities that offer Growth,
Value and Strong Potential Return
Thursday, September 3, 2015

Sarepta Therapeutics, Inc.

In-Depth Research Report Available for SRPT

Download Free Report Now

Company Profile SRPT

Sarepta Therapeutics shares declined 3.06 percent to close at $21.83 a share Wednesday. The stock traded between $21.72 and $22.50 on volume of 920,071 shares traded. Analysts at WBB Securities have recently upgraded the company’s rating to “buy” from “speculative buy”. Shares of Sarepta Therapeutics have gained approximately 7.0 percent year-to-date. Going forward ... (see research report)

News & Events SRPT